MTEM

Molecular Templates, Inc.
MTEM

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

MTEM was delisted on the 24th of December, 2024.

Back to rankings
 

About: Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

Employees: 62

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™